Evidence map›Paper›PMID 36041073›Full record

ArticleChemMedChem2022

Biomolecular Interactions of Cytotoxic Ruthenium Compounds with Thiosemicarbazone or Benzothiazole Schiff Base Chelates.

Sanam Maikoo, Bheki Xulu, Allen Mambanda, Ntando Mkhwanazi, Candace Davison, Jo-Anne de la Mare, Irvin Noel Booysen

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ChemMedChem, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sanam MaikooSchool of Chemistry and Physics, University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Bheki XuluSchool of Chemistry and Physics, University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Allen MambandaSchool of Chemistry and Physics, University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Ntando MkhwanaziCentre for Chemico and Biomedicinal Research, Department of Biochemistry and Microbiology, Faculty of Science, Rhodes University, PO Box 94, Grahamstown, 6140, South Africa.
Candace DavisonCentre for Chemico and Biomedicinal Research, Department of Biochemistry and Microbiology, Faculty of Science, Rhodes University, PO Box 94, Grahamstown, 6140, South Africa.
Jo-Anne de la MareCentre for Chemico and Biomedicinal Research, Department of Biochemistry and Microbiology, Faculty of Science, Rhodes University, PO Box 94, Grahamstown, 6140, South Africa.
Irvin Noel BooysenSchool of Chemistry and Physics, University of KwaZulu-Natal, Pietermaritzburg, South Africa.ORCID 0000-0001-9680-5978
Umkhuseli Innovation and Research Management · ZARhodes University · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein we illustrate the formation and characterization of new paramagnetic ruthenium compounds, trans-P-[RuCl(PPh

Indexed as

Antineoplastic AgentsCoordination ComplexesOrganometallic CompoundsRutheniumThiosemicarbazonesBenzothiazolesChloridesDimethyl SulfoxideDNADNA Topoisomerases, Type IIntercalating AgentsMethylene BluePhosphatesRuthenium CompoundsSchiff BasesSemicarbazidesAntineoplastic AgentsBenzothiazolesChloridesCoordination ComplexesDimethyl SulfoxideDNADNA Topoisomerases, Type IIntercalating AgentsMethylene BlueOrganometallic CompoundsPhosphatesRutheniumRuthenium CompoundsSchiff BasesSemicarbazidesthiosemicarbazideThiosemicarbazonesbenzothiazolebiomolecular interactionscytotoxicityRutheniumthiosemicarbazone

Identifiers

PMID36041073
PMCPMC9826503
OpenAlexW4293702882

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.